Article 23 Nov 2023 Following Recent Policy Statement, FTC 'Disputes' 100+ Patent Listings In FDA Orange Book United States IP
Article 20 Oct 2023 FTC Issues Antitrust Warning Against 'Improper' Orange Book Patent Listings United States Anti-trust
Article 31 Jan 2023 FDA Doubles Down On Its Pre-Catalyst Stance On Orphan Drug Exclusivity United States Healthcare
Article 03 Aug 2022 FDA Unveils Considerations For Rescinding Breakthrough Therapy Designation United States Healthcare
Article 10 Jun 2022 Liquid Biopsy Technology: FDA's Latest Guidance Supports Several Uses Of CtDNA In Clinical Trials, But Not (yet) As Surrogate Clinical Endpoint United States Healthcare
Article 18 Apr 2022 FDA Releases Draft Guidance On Development Of Genome Editing And CAR T Therapies United States Healthcare
Article 27 Dec 2021 DOJ Previews Enforcement Policies Aimed At Clinical Trial Fraud United States Criminal
Article 08 Jun 2020 COVID-19: Weekly Life Sciences Digest – Testing Kits For COVID-19 United States Coronavirus